The function of heparan sulfate during branching morphogenesis

Matrix Biology

Volumn 57-58, Issue , 2017, Pages 311-323

  Patel, Vaishali N ^a   Pineda, Dallas L ^a   Hoffman, Matthew P ^a  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

Branching morphogenesis; Extracellular matrix; FGF10; FGFR2b; Growth factors; Heparan sulfate; Heparan sulfate 3 O sulfotransferase

Indexed keywords

HEPARAN SULFATE; HEPARANASE; PROTEOHEPARAN SULFATE; SULFATASE; PROTEOGLYCAN; SIGNAL PEPTIDE;

BIOSYNTHESIS; BRANCHING MORPHOGENESIS; CELL INTERACTION; CHEMICAL MODIFICATION; EPITHELIUM CELL; EXTRACELLULAR MATRIX; HUMAN; NONHUMAN; ORGANOGENESIS; PRIORITY JOURNAL; REVIEW; SALIVARY GLAND; STEM CELL NICHE; ANIMAL; CHEMISTRY; CYTOLOGY; EXOCRINE GLAND; FEMALE; GROWTH, DEVELOPMENT AND AGING; KIDNEY; LIVER; LUNG; MALE; METABOLISM; PANCREAS; PHYSIOLOGY; PROSTATE; SIGNAL TRANSDUCTION; ULTRASTRUCTURE;

ANIMALS; EPITHELIAL CELLS; EXOCRINE GLANDS; EXTRACELLULAR MATRIX; FEMALE; HEPARITIN SULFATE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KIDNEY; LIVER; LUNG; MALE; ORGANOGENESIS; PANCREAS; PROSTATE; PROTEOGLYCANS; SIGNAL TRANSDUCTION;

EID: 85011088583     PISSN: 0945053X     EISSN: 15691802     Source Type: Journal    
DOI: 10.1016/j.matbio.2016.09.004     Document Type: Review

References (104)

1. [1] Patel, V.N., Hoffman, M.P., Salivary gland development: a template for regeneration. Semin. Cell Dev. Biol. 25-26 (2014), 52–60.
2. [2] Bonnans, C., Chou, J., Werb, Z., Remodelling the extracellular matrix in development and disease. Nat. Rev. Mol. Cell Biol. 15 (2014), 786–801.
3. [3] Daley, W.P., Yamada, K.M., ECM-modulated cellular dynamics as a driving force for tissue morphogenesis. Curr. Opin. Genet. Dev. 23 (2013), 408–414.
4. [4] Rozario, T., DeSimone, D.W., The extracellular matrix in development and morphogenesis: a dynamic view. Dev. Biol. 341 (2010), 126–140.
5. [5] Yurchenco, P.D., Basement membranes: cell scaffoldings and signaling platforms. Cold Spring Harb. Perspect. Biol., 3, 2011.
6. [6] Vlodavsky, I., Bar-Shavit, R., Ishai-Michaeli, R., Bashkin, P., Fuks, Z., Extracellular sequestration and release of fibroblast growth factor: a regulatory mechanism?. Trends Biochem. Sci. 16 (1991), 268–271.
7. [7] Allen, B.L., Rapraeger, A.C., Spatial and temporal expression of heparan sulfate in mouse development regulates FGF and FGF receptor assembly. J. Cell Biol. 163 (2003), 637–648.
8. [8] Shukla, D., et al. A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry. Cell 99 (1999), 13–22.
9. [9] Kleinman, H.K., Philp, D., Hoffman, M.P., Role of the extracellular matrix in morphogenesis. Curr. Opin. Biotechnol. 14 (2003), 526–532.
10. [10] Makarenkova, H.P., et al. Differential interactions of FGFs with heparan sulfate control gradient formation and branching morphogenesis. Sci. Signal., 2, 2009, ra55.
11. [11] Whitelock, J.M., Iozzo, R.V., Heparan sulfate: a complex polymer charged with biological activity. Chem. Rev. 105 (2005), 2745–2764.
12. [12] Norton, W.H., Ledin, J., Grandel, H., Neumann, C.J., HSPG synthesis by zebrafish Ext2 and Extl3 is required for Fgf10 signalling during limb development. Development 132 (2005), 4963–4973.
13. [13] Shackleton, M., et al. Generation of a functional mammary gland from a single stem cell. Nature 439 (2006), 84–88.
14. [14] Leong, K.G., Wang, B.E., Johnson, L., Gao, W.Q., Generation of a prostate from a single adult stem cell. Nature 456 (2008), 804–808.
15. [15] Maimets, M., et al. Long-term in vitro expansion of salivary gland stem cells driven by Wnt signals. Stem Cell Rep. 6 (2016), 150–162.
16. [16] Pringle, S., et al. Human salivary gland stem cells functionally restore radiation damaged salivary glands. Stem Cells 34 (2016), 640–652.
17. [17] Thompson, H.A., Spooner, B.S., Inhibition of branching morphogenesis and alteration of glycosaminoglycan biosynthesis in salivary glands treated with beta-D-xyloside. Dev. Biol. 89 (1982), 417–424.
18. [18] Thompson, H.A., Spooner, B.S., Proteoglycan and glycosaminoglycan synthesis in embryonic mouse salivary glands: effects of beta-D-xyloside, an inhibitor of branching morphogenesis. J. Cell Biol. 96 (1983), 1443–1450.
19. [19] Bernfield, M., Banerjee, S.D., The turnover of basal lamina glycosaminoglycan correlates with epithelial morphogenesis. Dev. Biol. 90 (1982), 291–305.
20. [20] Bernfield, M.R., Banerjee, S.D., Acid mucopolysaccharide (glycosaminoglycan) at the epithelial-mesenchymal interface of mouse embryo salivary glands. J. Cell Biol. 52 (1972), 664–673.
21. [21] Patel, V.N., Rebustini, I.T., Hoffman, M.P., Salivary gland branching morphogenesis. Differentiation 74 (2006), 349–364.
22. [22] Ornitz, D.M., Itoh, N., Fibroblast growth factors. Genome Biol., 2(REVIEWS3005), 2001.
23. [23] Lin, X., Buff, E.M., Perrimon, N., Michelson, A.M., Heparan sulfate proteoglycans are essential for FGF receptor signaling during Drosophila embryonic development. Development 126 (1999), 3715–3723.
24. [24] De Moerlooze, L., et al. An important role for the IIIb isoform of fibroblast growth factor receptor 2 (FGFR2) in mesenchymal-epithelial signalling during mouse organogenesis. Development 127 (2000), 483–492.
25. [25] Min, H., et al. Fgf-10 is required for both limb and lung development and exhibits striking functional similarity to Drosophila branchless. Genes Dev. 12 (1998), 3156–3161.
26. [26] Sekine, K., et al. Fgf10 is essential for limb and lung formation. Nat. Genet. 21 (1999), 138–141.
27. [27] Thacker, B.E., Xu, D., Lawrence, R., Esko, J.D., Heparan sulfate 3-O-sulfation: a rare modification in search of a function. Matrix Biol. 35 (2014), 60–72.
28. [28] Iozzo, R.V., Basement membrane proteoglycans: from cellar to ceiling. Nat. Rev. Mol. Cell Biol. 6 (2005), 646–656.
29. [29] Fukai, N., et al. Lack of collagen XVIII/endostatin results in eye abnormalities. EMBO J. 21 (2002), 1535–1544.
30. [30] Ylikarppa, R., et al. Lack of type XVIII collagen results in anterior ocular defects. FASEB J. 17 (2003), 2257–2259.
31. [31] Utriainen, A., et al. Structurally altered basement membranes and hydrocephalus in a type XVIII collagen deficient mouse line. Hum. Mol. Genet. 13 (2004), 2089–2099.
32. [32] Lin, Y., et al. Induced repatterning of type XVIII collagen expression in ureter bud from kidney to lung type: association with sonic hedgehog and ectopic surfactant protein C. Development 128 (2001), 1573–1585.
33. [33] Karihaloo, A., et al. Endostatin regulates branching morphogenesis of renal epithelial cells and ureteric bud. Proc. Natl. Acad. Sci. U. S. A. 98 (2001), 12509–12514.
34. [34] Cano-Gauci, D.F., et al. Glypican-3-deficient mice exhibit developmental overgrowth and some of the abnormalities typical of Simpson-Golabi-Behmel syndrome. J. Cell Biol. 146 (1999), 255–264.
35. [35] Grisaru, S., Cano-Gauci, D., Tee, J., Filmus, J., Rosenblum, N.D., Glypican-3 modulates BMP- and FGF-mediated effects during renal branching morphogenesis. Dev. Biol. 231 (2001), 31–46.
36. [36] Pellegrini, M., et al. Gpc3 expression correlates with the phenotype of the Simpson-Golabi-Behmel syndrome. Dev. Dyn. 213 (1998), 431–439.
37. [37] Saikali, Z., Sinnett, D., Expression of glypican 3 (GPC3) in embryonal tumors. Int. J. Cancer 89 (2000), 418–422.
38. [38] Patel, V.N., et al. Heparanase cleavage of perlecan heparan sulfate modulates FGF10 activity during ex vivo submandibular gland branching morphogenesis. Development 134 (2007), 4177–4186.
39. [39] Wiradjaja, F., DiTommaso, T., Smyth, I., Basement membranes in development and disease. Birth Defects Res. C Embryo Today 90 (2010), 8–31.
40. [40] Ornitz, D.M., FGFs, heparan sulfate and FGFRs: complex interactions essential for development. BioEssays 22 (2000), 108–112.
41. [41] Arikawa-Hirasawa, E., Watanabe, H., Takami, H., Hassell, J.R., Yamada, Y., Perlecan is essential for cartilage and cephalic development. Nat. Genet. 23 (1999), 354–358.
42. [42] Rossi, M., et al. Heparan sulfate chains of perlecan are indispensable in the lens capsule but not in the kidney. EMBO J. 22 (2003), 236–245.
43. [43] Kirn-Safran, C., Farach-Carson, M.C., Carson, D.D., Multifunctionality of extracellular and cell surface heparan sulfate proteoglycans. Cell. Mol. Life Sci. 66 (2009), 3421–3434.
44. [44] Zhou, Z., et al. Impaired angiogenesis, delayed wound healing and retarded tumor growth in perlecan heparan sulfate-deficient mice. Cancer Res. 64 (2004), 4699–4702.
45. [45] Iozzo, R.V., Schaefer, L., Proteoglycan form and function: a comprehensive nomenclature of proteoglycans. Matrix Biol. 42 (2015), 11–55.
46. [46] Whitelock, J.M., Melrose, J., Iozzo, R.V., Diverse cell signaling events modulated by perlecan. Biochemistry 47 (2008), 11174–11183.
47. [47] Williamson, R.A., et al. Dystroglycan is essential for early embryonic development: disruption of Reichert's membrane in Dag1-null mice. Hum. Mol. Genet. 6 (1997), 831–841.
48. [48] Henry, M.D., Campbell, K.P., A role for dystroglycan in basement membrane assembly. Cell 95 (1998), 859–870.
49. [49] Durbeej, M., et al. Dystroglycan binding to laminin alpha1LG4 module influences epithelial morphogenesis of salivary gland and lung in vitro. Differentiation 69 (2001), 121–134.
50. [50] Esko, J.D., Selleck, S.B., Order out of chaos: assembly of ligand binding sites in heparan sulfate. Annu. Rev. Biochem. 71 (2002), 435–471.
51. [51] Humphries, D.E., Sullivan, B.M., Aleixo, M.D., Stow, J.L., Localization of human heparan glucosaminyl N-deacetylase/N-sulphotransferase to the trans-Golgi network. Biochem. J. 325:Pt 2 (1997), 351–357.
52. [52] Crawford, B.E., Olson, S.K., Esko, J.D., Pinhal, M.A., Cloning, Golgi localization, and enzyme activity of the full-length heparin/heparan sulfate-glucuronic acid C5-epimerase. J. Biol. Chem. 276 (2001), 21538–21543.
53. [53] Lamanna, W.C., et al. The heparanome–the enigma of encoding and decoding heparan sulfate sulfation. J. Biotechnol. 129 (2007), 290–307.
54. [54] Lin, X., et al. Disruption of gastrulation and heparan sulfate biosynthesis in EXT1-deficient mice. Dev. Biol. 224 (2000), 299–311.
55. [55] Stickens, D., Zak, B.M., Rougier, N., Esko, J.D., Werb, Z., Mice deficient in Ext2 lack heparan sulfate and develop exostoses. Development 132 (2005), 5055–5068.
56. [56] Garner, O.B., et al. Stage-dependent regulation of mammary ductal branching by heparan sulfate and HGF-cMet signaling. Dev. Biol. 355 (2011), 394–403.
57. [57] Fan, G., et al. Targeted disruption of NDST-1 gene leads to pulmonary hypoplasia and neonatal respiratory distress in mice. FEBS Lett. 467 (2000), 7–11.
58. [58] Ringvall, M., et al. Defective heparan sulfate biosynthesis and neonatal lethality in mice lacking N-deacetylase/N-sulfotransferase-1. J. Biol. Chem. 275 (2000), 25926–25930.
59. [59] Pan, Y., Woodbury, A., Esko, J.D., Grobe, K., Zhang, X., Heparan sulfate biosynthetic gene Ndst1 is required for FGF signaling in early lens development. Development 133 (2006), 4933–4944.
60. [60] Pan, Y., et al. Bud specific N-sulfation of heparan sulfate regulates Shp2-dependent FGF signaling during lacrimal gland induction. Development 135 (2008), 301–310.
61. [61] Forsberg, E., et al. Abnormal mast cells in mice deficient in a heparin-synthesizing enzyme. Nature 400 (1999), 773–776.
62. [62] Holmborn, K., et al. Heparan sulfate synthesized by mouse embryonic stem cells deficient in NDST1 and NDST2 is 6-O-sulfated but contains no N-sulfate groups. J. Biol. Chem. 279 (2004), 42355–42358.
63. [63] Grobe, K., et al. Heparan sulfate and development: differential roles of the N-acetylglucosamine N-deacetylase/N-sulfotransferase isozymes. Biochim. Biophys. Acta 1573 (2002), 209–215.
64. [64] Crawford, B.E., et al. Loss of the heparan sulfate sulfotransferase, Ndst1, in mammary epithelial cells selectively blocks lobuloalveolar development in mice. PLoS One, 5, 2010, e10691.
65. [65] Huang, R., et al. De novo sequencing of complex mixtures of heparan sulfate oligosaccharides. Anal. Chem. 17 (2016), 5299–5307.
66. [66] Li, J.P., Glucuronyl C5-epimerase an enzyme converting glucuronic acid to iduronic acid in heparan sulfate/heparin biosynthesis. Prog. Mol. Biol. Transl. Sci. 93 (2010), 59–78.
67. [67] Li, J.P., et al. Targeted disruption of a murine glucuronyl C5-epimerase gene results in heparan sulfate lacking L-iduronic acid and in neonatal lethality. J. Biol. Chem. 278 (2003), 28363–28366.
68. [68] Bullock, S.L., Fletcher, J.M., Beddington, R.S., Wilson, V.A., Renal agenesis in mice homozygous for a gene trap mutation in the gene encoding heparan sulfate 2-sulfotransferase. Genes Dev. 12 (1998), 1894–1906.
69. [69] Shah, M.M., et al. Hs2st mediated kidney mesenchyme induction regulates early ureteric bud branching. Dev. Biol. 339 (2010), 354–365.
70. [70] Merry, C.L., et al. The molecular phenotype of heparan sulfate in the Hs2st −/− mutant mouse. J. Biol. Chem. 276 (2001), 35429–35434.
71. [71] Qu, X., et al. Lacrimal gland development and Fgf10-Fgfr2b signaling are controlled by 2-O- and 6-O-sulfated heparan sulfate. J. Biol. Chem. 286 (2011), 14435–14444.
72. [72] Habuchi, H., et al. Mice deficient in heparan sulfate 6-O-sulfotransferase-1 exhibit defective heparan sulfate biosynthesis, abnormal placentation, and late embryonic lethality. J. Biol. Chem. 282 (2007), 15578–15588.
73. [73] Izvolsky, K.I., Lu, J., Martin, G., Albrecht, K.H., Cardoso, W.V., Systemic inactivation of Hs6st1 in mice is associated with late postnatal mortality without major defects in organogenesis. Genesis 46 (2008), 8–18.
74. [74] Izvolsky, K.I., et al. Heparan sulfate-FGF10 interactions during lung morphogenesis. Dev. Biol. 258 (2003), 185–200.
75. [75] Izvolsky, K.I., et al. Heparan sulfates expressed in the distal lung are required for Fgf10 binding to the epithelium and for airway branching. Am. J. Phys. Lung Cell. Mol. Phys. 285 (2003), L838–L846.
76. [76] HajMohammadi, S., et al. Normal levels of anticoagulant heparan sulfate are not essential for normal hemostasis. J. Clin. Invest. 111 (2003), 989–999.
77. [77] Hasegawa, H., Wang, F., Visualizing mechanosensory endings of TrkC-expressing neurons in HS3ST-2-hPLAP mice. J. Comp. Neurol. 511 (2008), 543–556.
78. [78] Izvolsky, K.I., et al. Heparan sulfate–FGF10 interactions during lung morphogenesis. Dev. Biol. 258 (2003), 185–200.
79. [79] van Kuppevelt, T.H., Cremers, F.P., Domen, J.G., Kuyper, C.M., Staining of proteoglycans in mouse lung alveoli. II. Characterization of the Cuprolinic blue-positive, anionic sites. Histochem. J. 16 (1984), 671–686.
80. [80] Sannes, P.L., Differences in basement membrane-associated microdomains of type I and type II pneumocytes in the rat and rabbit lung. J. Histochem. Cytochem. 32 (1984), 827–833.
81. [81] Dowd, C.J., Cooney, C.L., Nugent, M.A., Heparan sulfate mediates bFGF transport through basement membrane by diffusion with rapid reversible binding. J. Biol. Chem. 274 (1999), 5236–5244.
82. [82] Patel, V.N., et al. Specific heparan sulfate structures modulate FGF10-mediated submandibular gland epithelial morphogenesis and differentiation. J. Biol. Chem. 283 (2008), 9308–9317.
83. [83] Patel, V.N., et al. Hs3st3-modified heparan sulfate controls KIT + progenitor expansion by regulating 3-O-sulfotransferases. Dev. Cell 29 (2014), 662–673.
84. [84] Nigam, S.K., Bush, K.T., Growth factor-heparan sulfate “switches” regulating stages of branching morphogenesis. Pediatr. Nephrol. 29 (2014), 727–735.
85. [85] Davies, J., Lyon, M., Gallagher, J., Garrod, D., Sulphated proteoglycan is required for collecting duct growth and branching but not nephron formation during kidney development. Development 121 (1995), 1507–1517.
86. [86] Steer, D.L., et al. Regulation of ureteric bud branching morphogenesis by sulfated proteoglycans in the developing kidney. Dev. Biol. 272 (2004), 310–327.
87. [87] Shah, M.M., et al. Growth factor-dependent branching of the ureteric bud is modulated by selective 6-O sulfation of heparan sulfate. Dev. Biol. 356 (2011), 19–27.
88. [88] Silberstein, G.B., Daniel, C.W., Glycosaminoglycans in the basal lamina and extracellular matrix of the developing mouse mammary duct. Dev. Biol. 90 (1982), 215–222.
89. [89] Bush, K.T., et al. N-sulfation of heparan sulfate regulates early branching events in the developing mammary gland. J. Biol. Chem. 287 (2012), 42064–42070.
90. [90] Zcharia, E., et al. Molecular properties and involvement of heparanase in cancer progression and mammary gland morphogenesis. J. Mammary Gland Biol. Neoplasia 6 (2001), 311–322.
91. [91] Zcharia, E., et al. Newly generated heparanase knock-out mice unravel co-regulation of heparanase and matrix metalloproteinases. PLoS One, 4, 2009, e5181.
92. [92] Gomes, A.M., et al. Mammary branching morphogenesis requires reciprocal signaling by heparanase and MMP-14. J. Cell. Biochem. 116 (2015), 1668–1679.
93. [93] Masola, V., Zaza, G., Onisto, M., Lupo, A., Gambaro, G., Impact of heparanase on renal fibrosis. J. Transl. Med., 13, 2015, 181.
94. [94] Dhoot, G.K., et al. Regulation of Wnt signaling and embryo patterning by an extracellular sulfatase. Science 293 (2001), 1663–1666.
95. [95] Holst, C.R., et al. Secreted sulfatases Sulf1 and Sulf2 have overlapping yet essential roles in mouse neonatal survival. PLoS One, 2, 2007, e575.
96. [96] Rosen, S.D., Lemjabbar-Alaoui, H., Sulf-2: an extracellular modulator of cell signaling and a cancer target candidate. Expert Opin. Ther. Targets 14 (2010), 935–949.
97. [97] Viviano, B.L., Paine-Saunders, S., Gasiunas, N., Gallagher, J., Saunders, S., Domain-specific modification of heparan sulfate by Qsulf1 modulates the binding of the bone morphogenetic protein antagonist Noggin. J. Biol. Chem. 279 (2004), 5604–5611.
98. [98] Wang, S., et al. QSulf1, a heparan sulfate 6-O-endosulfatase, inhibits fibroblast growth factor signaling in mesoderm induction and angiogenesis. Proc. Natl. Acad. Sci. U. S. A. 101 (2004), 4833–4838.
99. [99] Lamanna, W.C., et al. Heparan sulfate 6-O-endosulfatases: discrete in vivo activities and functional co-operativity. Biochem. J. 400 (2006), 63–73.
100. [100] Lum, D.H., Tan, J., Rosen, S.D., Werb, Z., Gene trap disruption of the mouse heparan sulfate 6-O-endosulfatase gene, Sulf2. Mol. Cell. Biol. 27 (2007), 678–688.
101. [101] Kowalewski, B., et al. Arylsulfatase G inactivation causes loss of heparan sulfate 3-O-sulfatase activity and mucopolysaccharidosis in mice. Proc. Natl. Acad. Sci. U. S. A. 109 (2012), 10310–10315.
102. [102] Liu, B.Y., McDermott, S.P., Khwaja, S.S., Alexander, C.M., The transforming activity of Wnt effectors correlates with their ability to induce the accumulation of mammary progenitor cells. Proc. Natl. Acad. Sci. U. S. A. 101 (2004), 4158–4163.
103. [103] Zcharia, E., et al. Transgenic expression of mammalian heparanase uncovers physiological functions of heparan sulfate in tissue morphogenesis, vascularization, and feeding behavior. FASEB J. 18 (2004), 252–263.
104. [104] Takashima, Y., et al. Heparan sulfate 6-O-endosulfatases, Sulf1 and Sulf2, regulate glomerular integrity by modulating growth factor signaling. Am. J. Physiol. Ren. Physiol. 310 (2016), F395–408.